Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β

Journal of Alzheimer's Disease

Volumn 43, Issue 1, 2014, Pages 153-165

  Wang, Xiu Lian ^a,c,d   Zeng, Ji ^b   Yang, Yang ^a,d   Xiong, Yan ^a,d   Zhang, Zhi Hua ^c   Qiu, Mei ^a,d   Yan, Xiong ^a,d   Sun, Xu Ying ^a,d   Tuo, Qing Zhang ^a,d   Liu, Rong ^a,d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; glycogen synthase kinase 3 ; Helicobacter pylori; tau hyperphosphorylation

Indexed keywords

CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MAPT PROTEIN, MOUSE; MAPT PROTEIN, RAT; PROTEIN KINASE INHIBITOR; TAU PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; ESCHERICHIA COLI; HELICOBACTER PYLORI; HIPPOCAMPUS; MALE; METABOLISM; MICROGLIA; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; ESCHERICHIA COLI; GLYCOGEN SYNTHASE KINASE 3; HELICOBACTER PYLORI; HIPPOCAMPUS; MALE; MICE; MICROGLIA; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 84908671922     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140198     Document Type: Article

References (45)

1. Mount C, Downton C (2006) Alzheimer disease: Progress or profit? Nat Med 12, 780-784.
2. Kelley BJ, Petersen RC (2007) Alzheimers disease and mild cognitive impairment. Neurol Clin 25, 577-609.
3. Braak H, Braak E (1992) The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15, 6-31.
4. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089.
5. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimers disease. Neurology 42, 631-639.
6. Johnson GV, Hartigan JA (1999) Tau protein in normal and Alzheimers disease brain: An update. J Alzheimers Dis 1, 329-351.
7. Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30, 11938-11950.
8. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081.
9. Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimers disease and infection: Do infectious agents contribute to progression of Alzheimers disease? Alzheimers Dement 5, 348-360.
10. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G (2004) Helicobacter pylori and Alzheimers disease: A possible link. Eur J Intern Med 15, 381-386.
11. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66, 938-940.
12. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D (2009) Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimers disease. Int J Neurosci 119, 765-777.
13. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D(2009) Eradication of Helicobacter pylori may be beneficial in the management of Alzheimers disease. J Neurol 256, 758-767.
14. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S, Katsinelos P, Grigoriadis N, Giartza- Taxidou E, Venizelos I (2010) Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 23, 199-204.
15. Chang YP, Chiu GF, Kuo FC, Lai CL, Yang YH, Hu HM, ChangPY, ChenCY,Wu DC,Yu FJ (2013) Eradication of helicobacter pylori is associated with the progression of dementia: A Population-Based study. Gastroenterol Res Pract 2013, 175729.
16. Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, Megraud F, SallesN(2012) Impact of chronic Helicobacter pylori infection on Alzheimers disease: Preliminary results. Neurobiol Aging 33, 1009-1011.
17. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, Imahori K (1993) Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325, 167-172.
18. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S (1994) Alzheimers disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4, 1077-1086.
19. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58, 1010-1019.
20. Gong CX, Shaikh S,Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K(1995) Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J Neurochem 65, 732-738.
21. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950.
22. Ohkusa T, Okayasu I, Miwa H, Ohtaka K, Endo S, Sato N (2003) Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut 52, 797-803.
23. Keates S, Keates AC, Warny M, Peek RJ, Murray PG, Kelly CP (1999) Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol 163, 5552-5559.
24. Marshall BJ,Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315.
25. QureshiWA, Graham DY (1999) Diagnosis and management of Helicobacter pylori infection. Clin Cornerstone 1, 18-28.
26. Sipponen P, Hyvarinen H (1993) Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl 196, 3-6.
27. Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T, Chatzopoulos D, Venizelos I (2005) Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 12, 139-143.
28. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D,CammAJ, NorthfieldTC(1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71, 437-439.
29. Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: Biology and disease. J Clin Invest 113, 321-333.
30. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, Hayashi J (2005) Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis 178, 303-309.
31. Clyne M, Labigne A, Drumm B (1995) Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 63, 1669-1673.
32. Wyatt JI, Rathbone BJ, DixonMF, HeatleyRV(1987)Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 40, 841-848.
33. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD (1991) Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 87, 894-900.
34. Pai R, Wyle FA, Cover TL, Itani RM, Domek MJ, Tarnawski AS (1998) Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells. Am J Pathol 152, 1617-1624.
35. Santarelli L, Gabrielli M, Cremonini F, Santoliquido A, Candelli M, Nista EC, Pola P, Gasbarrini G, Gasbarrini A (2004) Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther 19, 107-111.
36. Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M (2007) Elevated homocysteine levels in patients with slow coronary flow: Relationship with Helicobacter pylori infection. Helicobacter 12, 298-305.
37. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, DAgostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimers disease. N Engl J Med 346, 476-483.
38. Morris MS (2003) Homocysteine and Alzheimers disease. Lancet Neurol 2, 425-428.
39. McManus RM, Higgins SC, Mills KH, Lynch MA (2014) Respiratory infection promotes T cell infiltration and amyloid-beta deposition in APP/PS1 mice. Neurobiol Aging 35, 109-121.
40. Trojanowski JQ, Lee VM (1995) Phosphorylation of paired helical filament tau in Alzheimers disease neurofibrillary lesions: Focusing on phosphatases. FASEB J 9, 1570-1576.
41. Isomoto H, Moss J, Hirayama T (2010) Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. Tohoku J Exp Med 220, 3-14.
42. Sokolova O, Bozko PM, Naumann M (2008) Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem 283, 29367-29374.
43. Nakayama M, Hisatsune J, Yamasaki E, Isomoto H, Kurazono H, Hatakeyama M, Azuma T, Yamaoka Y, Yahiro K, Moss J (2009) Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem 284, 1612-1619.
44. Yao XQ, Zhang XX,YinYY, Liu B, Luo DJ, Liu D, Chen NN, Ni ZF,Wang X,Wang Q,Wang JZ, Liu GP (2011) Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem J 437, 335-344.
45. Liu GP, Zhang Y, Yao XQ, Zhang CE, Fang J, Wang Q, Wang JZ (2008) Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol Aging 29, 1348-1358.